Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Microbiology, epidemiology, and pathogenesis of Rhodococcus equi infections

Camille N Kotton, MD
Section Editor
Daniel J Sexton, MD
Deputy Editor
Jennifer Mitty, MD, MPH


Rhodococcus equi has been recognized as an animal pathogen since its original isolation as Corynebacterium equi in 1923 from foals with pneumonia. Foals less than six months old are uniquely susceptible to the development of a chronic suppurative bronchopneumonia that can lead to lung and bronchial lymph node abscesses, sometimes called "rattles" [1]. Ulcerative colitis and mesenteric adenitis may also occur, usually associated with pulmonary infection. In swine, R. equi is commonly isolated from the lymph nodes of animals with submaxillary adenitis. The organism can rarely cause pulmonary and extrapulmonary abscesses, wound infections, and lymphadenitis in other animals, primarily rooting and grazing mammals. However, when hosts other than foals and swine develop R. equi infections, they are frequently immunocompromised [2].

The first case of human infection was reported in 1967 [3]; only 12 additional cases were reported in the next 15 years [4]. While still rare, R. equi has been isolated increasingly, especially as an opportunistic pathogen. Most human infections have been associated with immune system dysfunction, and a dramatic increase occurred in the setting of human immunodeficiency virus (HIV) infection [5-14]. In addition, improved laboratory identification of infections in both immunocompromised and normal humans has led to increasing recognition of R. equi as a pathogen.

The microbiology, pathogenesis, and epidemiology of R. equi infections will be reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of these infections are discussed separately. (See "Clinical features; diagnosis; therapy; and prevention of Rhodococcus equi infections".)


R. equi was originally named C. equi in 1923 based upon its morphologic appearance. Subsequently, the cell wall composition and biochemical reactions were found to be more closely related to Nocardia and mycobacteria than corynebacteria; in 1980, the organism was reclassified in the genus Rhodococcus. (See "Microbiology, epidemiology, and pathogenesis of nocardiosis" and "Natural history, microbiology, and pathogenesis of tuberculosis".)

Part of the phylogenetic group of nocardioform actinomycetes, Rhodococcus is characterized in part by rod-to-coccus growth cycle variation and the presence of tuberculostearic acid and cell wall mycolic acids [2]. Little is known about the pathogenic potential of rhodococci other than R. equi. Some have been isolated from granulomatous lesions in humans [2], but reports of disease are rare.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Sep 2016. | This topic last updated: Jul 20, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
  1. Muscatello G, Leadon DP, Klayt M, et al. Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet J 2007; 39:470.
  2. Prescott JF. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev 1991; 4:20.
  3. Golub B, Falk G, Spink WW. Lung abscess due to Corynebacterium equi. Report of first human infection. Ann Intern Med 1967; 66:1174.
  4. Van Etta LL, Filice GA, Ferguson RM, Gerding DN. Corynebacterium equi: a review of 12 cases of human infection. Rev Infect Dis 1983; 5:1012.
  5. Harvey RL, Sunstrum JC. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 1991; 13:139.
  6. Emmons W, Reichwein B, Winslow DL. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case. Rev Infect Dis 1991; 13:91.
  7. Lasky JA, Pulkingham N, Powers MA, Durack DT. Rhodococcus equi causing human pulmonary infection: review of 29 cases. South Med J 1991; 84:1217.
  8. Drancourt M, Bonnet E, Gallais H, et al. Rhodococcus equi infection in patients with AIDS. J Infect 1992; 24:123.
  9. Verville TD, Huycke MM, Greenfield RA, et al. Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) 1994; 73:119.
  10. Scott MA, Graham BS, Verrall R, et al. Rhodococcus equi--an increasingly recognized opportunistic pathogen. Report of 12 cases and review of 65 cases in the literature. Am J Clin Pathol 1995; 103:649.
  11. Donisi A, Suardi MG, Casari S, et al. Rhodococcus equi infection in HIV-infected patients. AIDS 1996; 10:359.
  12. Arlotti M, Zoboli G, Moscatelli GL, et al. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand J Infect Dis 1996; 28:463.
  13. Hsueh PR, Hung CC, Teng LJ, et al. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin Infect Dis 1998; 27:370.
  14. Torres-Tortosa M, Arrizabalaga J, Villanueva JL, et al. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases. Chest 2003; 123:1970.
  15. Mutimer MD, Woolcock JB. A note on hydrolytic enzymes of Corynebacterium equi. J Appl Bacteriol 1983; 55:367.
  16. Nakazawa M, Kubo M, Sugimoto C, Isayama Y. Serogrouping of Rhodococcus equi. Microbiol Immunol 1983; 27:837.
  17. Vila J, Juiz P, Salas C, et al. Identification of clinically relevant Corynebacterium spp., Arcanobacterium haemolyticum, and Rhodococcus equi by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2012; 50:1745.
  18. Pilares L, Agüero J, Vázquez-Boland JA, et al. Identification of atypical Rhodococcus-like clinical isolates as Dietzia spp. by 16S rRNA gene sequencing. J Clin Microbiol 2010; 48:1904.
  19. Barton MD, Hughes KL. Ecology of Rhodococcus equi. Vet Microbiol 1984; 9:65.
  20. Muscatello G, Anderson GA, Gilkerson JR, Browning GF. Associations between the ecology of virulent Rhodococcus equi and the epidemiology of R. equi pneumonia on Australian thoroughbred farms. Appl Environ Microbiol 2006; 72:6152.
  21. Cohen ND, Kuskie KR, Smith JL, et al. Association of airborne concentration of virulent Rhodococcus equi with location (stall versus paddock) and month (January through June) on 30 horse breeding farms in central Kentucky. Am J Vet Res 2012; 73:1603.
  22. Zink MC, Yager JA, Prescott JF, Fernando MA. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet Microbiol 1987; 14:295.
  23. Bowles PM, Woolcock JB, Mutimer MD. Experimental infection of mice with Rhodococcus equi: differences in virulence between strains. Vet Microbiol 1987; 14:259.
  24. Nakazawa M, Haritani M, Sugimoto C, Isayama Y. Virulence of Rhodococcus equi for mice. Nihon Juigaku Zasshi 1983; 45:679.
  25. Takai S, Michizoe T, Matsumura K, et al. Correlation of in vitro properties of Rhodococcus (Corynebacterium) equi with virulence for mice. Microbiol Immunol 1985; 29:1175.
  26. Takai S, Koike K, Ohbushi S, et al. Identification of 15- to 17-kilodalton antigens associated with virulent Rhodococcus equi. J Clin Microbiol 1991; 29:439.
  27. Takai S, Sekizaki T, Ozawa T, et al. Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi. Infect Immun 1991; 59:4056.
  28. Takai S, Madarame H, Matsumoto C, et al. Pathogenesis of Rhodococcus equi infection in mice: roles of virulence plasmids and granulomagenic activity of bacteria. FEMS Immunol Med Microbiol 1995; 11:181.
  29. Takai S, Imai Y, Fukunaga N, et al. Identification of virulence-associated antigens and plasmids in Rhodococcus equi from patients with AIDS. J Infect Dis 1995; 172:1306.
  30. Takai S, Fukunaga N, Ochiai S, et al. Identification of intermediately virulent Rhodococcus equi isolates from pigs. J Clin Microbiol 1996; 34:1034.
  31. Scannell KA, Portoni EJ, Finkle HI, Rice M. Pulmonary malacoplakia and Rhodococcus equi infection in a patient with AIDS. Chest 1990; 97:1000.
  32. Akilesh S, Cross S, Kimmelshue K, et al. Pseudotumor of the tracheal-laryngeal junction with unusual morphologic features caused by Rhodococcus equi infection. Head Neck Pathol 2011; 5:395.
  33. Mulè A, Petrone G, Santoro A, et al. Pulmonary malacoplakia at early stage: use of polymerase chain reaction for detection of Rhodococcus equi. Int J Immunopathol Pharmacol 2012; 25:703.
  34. Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992; 327:293.
  35. Germain P, Deville J, Remy G, Dropsy G. A propos d'une observation d'infection humaine à Corynebacterium equi. Med Mal Infect 1975; 5:294.
  36. Peloux Y, Durand JM, Fosse T. Péritonite à Corynebacterium (Rhodococcus) equi chez un cirrhotique. Sem Hôp Paris 1985; 61:2441.
  37. Ardans AA, Hietala SK, Spensley MS, Sansome A. Studies of naturally occurring and experimental Rhodococcus equi (Corynebacterium equi) pneumonia in foals. Proc Am Assoc Equine Pract 1986; 32:129.
  38. Martens RJ, Martens JG, Fiske RA, Hietala SK. Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals. Equine Vet J 1989; 21:249.
  39. Ellenberger MA, Kaeberle ML, Roth JA. Equine cell-mediated immune response to Rhodococcus (Corynebacterium) equi. Am J Vet Res 1984; 45:2424.
  40. Nordmann P, Ronco E, Guenounou M. Involvement of interferon-gamma and tumor necrosis factor-alpha in host defense against Rhodococcus equi. J Infect Dis 1993; 167:1456.
  41. Shahani L. Rhodococcus equi pneumonia and sepsis in an allogeneic haematopoietic stem cell transplant recipient. BMJ Case Rep 2014; 2014.
  42. Kotton CN. Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. Clin Infect Dis 2007; 44:857.
  43. Menon V, Gottlieb T, Gallagher M, Cheong EL. Persistent Rhodococcus equi infection in a renal transplant patient: case report and review of the literature. Transpl Infect Dis 2012; 14:E126.
  44. Nordmann P, Ronco E, Nauciel C. Role of T-lymphocyte subsets in Rhodococcus equi infection. Infect Immun 1992; 60:2748.
  45. Hietala SK, Ardans AA. Interaction of Rhodococcus equi with phagocytic cells from R. equi-exposed and non-exposed foals. Vet Microbiol 1987; 14:307.
  46. Vullo V, Mastroianni CM, Lichtner M, et al. Serologic responses to Rhodococcus equi in individuals with and without human immunodeficiency virus infection. Eur J Clin Microbiol Infect Dis 1996; 15:588.